Laminin switches terminal differentiation fate of human trophoblast stem cells under chemically defined culture conditions.


Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
05 2023
Historique:
received: 22 07 2022
revised: 16 03 2023
accepted: 22 03 2023
medline: 29 5 2023
pubmed: 28 3 2023
entrez: 27 3 2023
Statut: ppublish

Résumé

Human trophoblast stem cells (hTSCs) have emerged as a powerful tool to model early placental development in vitro. Analogous to the epithelial cytotrophoblast in the placenta, hTSCs can differentiate into cells of the extravillous trophoblast (EVT) lineage or the multinucleate syncytiotrophoblast (STB). Here we present a chemically defined culture system for STB and EVT differentiation of hTSCs. Notably, in contrast to current approaches, we neither utilize forskolin for STB formation nor transforming growth factor-beta (TGFβ) inhibitors or a passage step for EVT differentiation. Strikingly, the presence of a single additional extracellular cue-laminin-111-switched the terminal differentiation of hTSCs from STB to the EVT lineage under these conditions. In the absence of laminin-111, STB formation occurred, with cell fusion comparable to that obtained with differentiation mediated by forskolin; however, in the presence of laminin-111, hTSCs differentiated to the EVT lineage. Protein expression of nuclear hypoxia-inducible factors (HIF1α and HIF2α) was upregulated during EVT differentiation mediated by laminin-111 exposure. A heterogeneous mixture of Notch1

Identifiants

pubmed: 36972789
pii: S0021-9258(23)00292-2
doi: 10.1016/j.jbc.2023.104650
pmc: PMC10176266
pii:
doi:

Substances chimiques

Colforsin 1F7A44V6OU
HLA-G Antigens 0
Laminin 0
Transforming Growth Factor beta 0
Culture Media 0
Hypoxia-Inducible Factor 1, alpha Subunit 0
endothelial PAS domain-containing protein 1 1B37H0967P

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

104650

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD101485
Pays : United States

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.

Auteurs

Victoria Karakis (V)

Department of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, North Carolina, USA.

Mahe Jabeen (M)

Department of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, North Carolina, USA.

John W Britt (JW)

Department of Genetics, North Carolina State University, Raleigh, North Carolina, USA.

Abigail Cordiner (A)

Department of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, North Carolina, USA.

Adam Mischler (A)

Department of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, North Carolina, USA.

Feng Li (F)

Department of Pathology and Laboratory Medicine, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, USA.

Adriana San Miguel (A)

Department of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, North Carolina, USA.

Balaji M Rao (BM)

Department of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, North Carolina, USA; Golden LEAF Biomanufacturing Training and Education Center, North Carolina State University, Raleigh, North Carolina, USA. Electronic address: bmrao@ncsu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH